deaths related to semaglutide Reduces Cardiovascular and COVID Death Ozempic Death Lawsuit Claims [August

GIP (Glucose-dependent Insulinotropic Polypeptide): Another incretin hormone produced in the intestines Stimulates insulin secretion from the pancreas Enhances fat metabolism Affects how the body stores and uses energy May amplify the appetite-suppressing effects of GLP-1 The Combined Effect: When both GLP-1 and GIP pathways are activated together: Stronger insulin response: better blood sugar control Enhanced fat burning: greater weight loss More appetite suppression: reduced food intake Slower gastric emptying: prolonged fullness (and potential problems) Clinical Advantages of Tirzepatide Greater Weight Loss: Clinical trials showed tirzepatide produced: Average weight loss: 20-25% of body weight Compared to semaglutide: 15-20% Some patients lost 30%+ of their starting weight Faster Results: Many patients report: Quicker onset of appetite suppression More rapid weight loss in the first months Stronger fullness sensation after meals Superior Glucose Control: For diabetic patients: Greater A1C reductions than semaglutide More patients reaching target A1C goals Fewer patients needing additional diabetes medications Potential Disadvantages and Risks 1

Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, et al

doi: 10.1093/bioinformatics/btae262 195 Castillo-HairSMSeeligG

20 Sochovsky, N

Neural stem/precursor cells (NPCs) are mitotically active, self-renewing and multipotent cells able to differentiate into astrocytes, oligodendrocytes and neurons and to migrate into specific biological niches or damaged areas promoting functional and structural repair 2

Early data suggests even greater weight loss than semaglutide alone